Changing Epidemiology of Bacterial Meningitis Since Introduction of Conjugate Vaccines: Three Decades of National Meningitis Surveillance in The Netherlands

Bacterial Infections

Vaccine preventable invasive bacterial diseases in Italy: A comparison between the national surveillance system and recorded hospitalizations, 2007-2016

Vaccine.

Pezzotti P, Bellino S, Riccardo F, Lucaroni F, Cerquetti M, Pantosti A, Rezza G, Stefanelli P

doi: 10.1016/j.vaccine.2018.11.047.

Further Publications Infectiology

Global Rotavirus and Pneumococcal Conjugate Vaccine Introductions and the Association With Country Disease Surveillance, 2006-2018

J Infect Dis

Peck ME, Hampton LM, Antoni S, Ogbuanu I, Serhan F, Nakamura T, Walldorf JA, Cohen AL

doi: 10.1093/infdis/jiab069

Viral Infections, Non-HIV

Continued Evidence of the Impact of Rotavirus Vaccine in Children Less than 3 Years of Age from the US New Vaccine Surveillance Network- a Multi-Site Active Surveillance Program, 2006-2016

Clin Infect Dis.

Staat MA, Payne DC, Halasa N, Weinberg GA, Donauer S, Wikswo M, McNeal M, Edwards KM, Szilagyi PG, Bernstein DI, Curns AT, Sulemana I, Esona MD, Bowen MD, Parashar UD, and the New Vaccine Surveillance Network (NVSN).

doi: 10.1093/cid/ciaa150.

Bacterial Infections

Characteristics of invasive pneumococcal disease (IPD) caused by emerging serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) in England; prospective observational cohort study, 2014-18

Clin Infect Dis.

Amin-Chowdhury Z, Collins S, Sheppard C, Litt D, Fry NK, Andrews N, Ladhani SN

doi: 10.1093/cid/ciaa043.

Viral Infections, Non-HIV

Who is at risk of 13-valent conjugated pneumococcal vaccine failure?

Vaccine.

Yildirim M, Keskinocak P, Pelton S, Pickering L, Yildirim I

doi: 10.1016/j.vaccine.2019.12.060.

Viral Infections, Non-HIV

Effectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study

Lancet Infect Dis.

Monge S, Hahné SJ, de Melker HE, Sanders EA, van der Ende A, Knol MJ

doi: 10.1016/S1473-3099

Meningitis

The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination

J Infect.

Parikh S, Campbell H, Bettinger JA, Harrison LH, Marshall HS, Martinon-Torres F, Safadi MA, Shao Z, Zhu B, von Gottberg A, Borrow R, Ramsay ME, Ladhani SN

doi: 10.1016/j.jinf.2020.05.079.

Bacterial Infections

Changes in invasive pneumococcal disease spectrum after 13 valent pneumococcal conjugate vaccine implementation

Clin Infect Dis.

Levy C, Varon E, Ouldali N, Béchet S, Bonacorsi S, Cohen R

doi: 10.1093/cid/ciz221.

Meningitis

Invasive Haemophilus influenzae type b (Hib) disease in children in Italy, after 20 years of routine use of conjugate Hib vaccines

Vaccine

Giufrè M, Lindh E, Cardines R, Pezzotti P, Cerquetti M

doi: 10.1016/j.vaccine.2020.08.022

Related content

Vaccine preventable invasive bacterial diseases in Italy: A comparison between the national surveillance system and recorded hospitalizations, 2007-2016

Global Rotavirus and Pneumococcal Conjugate Vaccine Introductions and the Association With Country Disease Surveillance, 2006-2018

Continued Evidence of the Impact of Rotavirus Vaccine in Children Less than 3 Years of Age from the US New Vaccine Surveillance Network- a Multi-Site Active Surveillance Program, 2006-2016

Characteristics of invasive pneumococcal disease (IPD) caused by emerging serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) in England; prospective observational cohort study, 2014-18

Who is at risk of 13-valent conjugated pneumococcal vaccine failure?

Effectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study

The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination

Changes in invasive pneumococcal disease spectrum after 13 valent pneumococcal conjugate vaccine implementation

Invasive Haemophilus influenzae type b (Hib) disease in children in Italy, after 20 years of routine use of conjugate Hib vaccines